Indian pharmacy law organises every drug, cosmetic and manufacturing requirement into schedules appended to the Drugs and Cosmetics Rules, 1945. There are around twenty-five of them, running from Schedule A to Schedule Y, and they do entirely different jobs. Some control what a doctor may prescribe. Some control how a factory must be built. Some are simply lists of forms or fees.
Most practising doctors know four of them — G, H, H1 and X — and know those four imperfectly. This guide sets out what each schedule does, and then goes into detail on the ones that actually govern prescribing, because those are the ones that produce prosecutions.
"A doctor does not need to know all twenty-five schedules. A doctor needs to know four cold — G, H, H1 and X — and needs to know that the others exist so that when a drugs inspector cites Schedule K or Schedule P, the reference is not a mystery."
— Dr. Namit Gupta, Senior Medico-Legal Expert
The Four Schedules That Govern Prescribing
If you read nothing else, read this table. These four schedules determine whether a prescription you write today is legally valid.
| Schedule | What it covers | Prescription requirement | Typical drugs |
|---|---|---|---|
| G | Drugs requiring the warning "Caution: it is dangerous to take this preparation except under medical supervision" | Must carry the statutory caution on the label; taken under medical supervision | Antineoplastics and other agents requiring supervision |
| H | Prescription drugs — not to be sold without the prescription of a registered medical practitioner | Valid prescription, single copy | Most antibiotics, cardiac drugs, most modern therapeutics |
| H1 | A stricter subset of H, introduced to combat antimicrobial resistance and habit formation | Prescription plus a separate register retained for three years; distinctive red-box warning label | Third-generation antibiotics, anti-TB drugs, some habit-forming drugs |
| X | Psychotropic and dependence-forming substances — sixteen in all | Prescription in duplicate, separate retail licence (Form 20F), locked segregated storage, dedicated bound register, prescription retained two years | Barbiturates, amphetamines, methylphenidate, ketamine |
These are covered in full in our detailed articles on Schedule H and H1 and Schedule X.
Schedule G: the Forgotten One
Schedule G sits oddly in the hierarchy because it is not primarily about who may sell the drug — it is about what the label must say. A Schedule G drug must carry the caution that it is dangerous to take the preparation except under medical supervision.
In practice, a substantial number of Schedule G drugs are also Schedule H drugs, and the two obligations stack: the prescription requirement comes from H, the labelling warning from G. Doctors routinely assume that because a drug is "Schedule H" the Schedule G caution is irrelevant. It is not, and for a manufacturer or pharmacy the labelling defect is a contravention in its own right.
Schedules C and C1: Biologicals
Schedule C covers biological products and special products — sera, vaccines, antibiotics, insulin, and products for parenteral use. Schedule C1 covers other drugs of biological origin intended for oral administration, including certain hormones, vitamins and antibiotics.
The significance is licensing and cold chain rather than prescribing. Manufacture and sale of Schedule C and C1 products attract separate licensing requirements, and storage conditions are enforceable. For hospitals, the practical exposure is vaccine and insulin cold-chain failure, which is a documentation problem long before it is a clinical one.
The Remaining Schedules
| Schedule | What it deals with |
|---|---|
| A | Prescribed forms — applications, licences, notices under the Rules |
| B | Fees for test or analysis by Central Drugs Laboratories and Government Analysts |
| C, C1 | Biological and special products (see above) |
| D | Drugs exempted from certain import provisions |
| E1 | List of poisonous substances under Ayurvedic, Siddha and Unani systems |
| F | Requirements for blood banks, blood components and related products |
| G | Drugs requiring the "dangerous except under medical supervision" caution |
| H, H1 | Prescription drugs, and the stricter H1 subset |
| J | Diseases and ailments which a drug may not claim to prevent or cure |
| K | Drugs exempted from certain provisions — including drugs not for medicinal use, supply by government hospitals and by registered medical practitioners, and contraceptives |
| M | Good Manufacturing Practices — premises, plant, equipment, waste disposal |
| N | Minimum requirements and equipment for a pharmacy |
| P, P1 | Life period (shelf life) of drugs; pack sizes |
| Q | Permitted dyes, colours and pigments in cosmetics |
| R | Standards for condoms and other mechanical contraceptives |
| S | Standards for cosmetics |
| T | Good Manufacturing Practices for Ayurvedic, Siddha and Unani medicines |
| U | Particulars to be shown in manufacturing records of drugs |
| V | Standards for patent and proprietary medicines |
| X | Psychotropic and dependence-forming substances |
| Y | Requirements for import and manufacture of new drugs and for clinical trials |
Schedule J: the One Advertising Regulators Use
Schedule J is a list of diseases and ailments which a drug may not claim to prevent or cure. Under Rule 106, no drug may be advertised or labelled as treating or preventing anything on that list.
This matters far beyond manufacturers. A clinic website, a social media post, or a printed brochure claiming that a treatment cures a Schedule J condition is exposed — and the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 operates alongside it. Doctors who advertise services online are frequently unaware that the claim, not the treatment, is the offence.
Schedule K: the Exemptions Doctors Rely On Without Knowing
Schedule K lists drugs and situations exempted from certain provisions of the Rules. Among the exemptions of practical importance to practitioners are those relating to drugs supplied by government hospitals and dispensaries, drugs supplied by a registered medical practitioner to their own patients, drugs not intended for medicinal use, and certain contraceptives.
The exemption that doctors most often assume is wider than it is concerns dispensing to one's own patients. It is conditional, and it does not convert a consulting room into a licensed pharmacy. A doctor stocking and supplying drugs at scale, to patients other than their own, or in a manner indistinguishable from retail sale, is outside it.
Schedule Y and Clinical Trials
Schedule Y historically governed the requirements for import and manufacture of new drugs and for the conduct of clinical trials. Anyone working in clinical research should note that this area was substantially restructured by the New Drugs and Clinical Trials Rules, 2019, which now carry much of the regulatory load. Schedule Y should not be treated as the current, complete statement of clinical trial requirements without checking the 2019 Rules.
How the Schedules Interact
The single most useful thing to understand is that the schedules are cumulative, not alternative. A drug can sit in several at once, and each obligation applies independently:
- A drug may be in Schedule G and H — requiring both the caution on the label and a valid prescription.
- A drug may be in Schedule H and X — the Schedule X requirements govern, because they are stricter.
- A drug may be in Schedule X and also fall under the NDPS Act, 1985. NDPS compliance is additional, not alternative, and its penalties are far heavier.
- A biological in Schedule C that is also a prescription drug carries both the licensing and cold-chain obligations and the Schedule H prescription requirement.
Satisfying one schedule never discharges another.
Conclusion
Twenty-five schedules sound like a body of law nobody could hold in their head, and no clinician needs to. The prescribing schedules are four, the interaction rule is one line — obligations stack, they do not substitute — and the rest are best treated as a reference you consult when a notice arrives citing one of them.
The two that most often catch clinicians out are the ones furthest from prescribing: Schedule J, because a claim on a clinic website is an offence in a way that the underlying treatment is not, and Schedule K, because the exemption for supplying drugs to one's own patients is narrower than the practice built on it.